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background: Occlusion of the left atrial appendage (LAA) using the WATCHMAN® device proofed its safety and efficacy in the PROTECT-AF trial and 
found its way into daily clinical routine since then. However, patients with known thrombus formation within the LAA are excluded from this technique 
so far because of the high risk of embolization during the procedure in these patients. We report the first two cases of successful LAA occlusion using 
the WATHCMAN® device and cerebral protection systems in patients with known thrombus within the LAA.
methods and results: In the first case, a patient on chronic dialysis for end stage kidney failure developed a LAA thrombus despite treatment 
with heparin. The second patient showed a persistent thrombus formation despite proper oral anticoagulation. Both patients were successfully 
treated with a WATCHMAN® device without procedural complications. As cerebral protection devices a SpiderFX® system was used in the first case 
and a Claret Medical Montage® for the second patient. For implantation, the delivery sheath is usually positioned distally within the LAA and the 
device is set free by retracting the sheath. In order to further reduce the risk for thrombus embolization the delivery sheath was positioned at the LAA 
ostium and the device was unfolded by pushing it forward into the LAA in the first patient. Allthough the implantation was successful, this technique 
led to a reduced predictability of the position in which the device would sit after unfolding. Therefore, we changed the strategy for the second case 
and used the standard technique with pigtail and delivery sheath placement within the LAA in this case. 
conclusions: LAA occlusion with cerebral protection devices is feasible in selected patients with LAA thrombus at high risk for embolic 
complications but still has to be regarded as a high-risk procedure.
